Objective To investigate the prevalence,natural history,and causes of death of nonalcoholic fatty liver disease( NAFLD),as well as related influencing factors. Methods A total of 833 retired cadres and staff members who underwent physical examination in Shanghai Changzheng Hospital and Shanghai 85 Hospital of the PLA from January 1 to December 31,2011 and received follow- up visits in either hospital every year since 2011 were enrolled as study subjects,and were divided into NAFLD group( 459 patients who were diagnosed with NAFLD before December 31,2011) and control group( 374 patients without liver or biliary diseases). The patients' clinical data were collected,including body height,body weight,systolic pressure,diastolic pressure,blood biochemical parameters,presence or absence of diabetes,hyperlipidemia,cerebrovascular and cardiovascular diseases,and malignant tumor,and smoking and drinking,and the death time and causes of death were clarified for the patients who died. The prevalence and natural course of NAFLD and related risk factors and prognostic factors were analyzed in this population. The t- test was applied for comparison of continuous data between groups,the chi- square test was applied for comparison of categorical data between groups,the multivariate binary logistic regression was applied to analyze the risk factors for the pathogenesis of NAFLD,and the multinomial logistic regression was applied to analyze the influencing factors for aggravation or alleviation of NAFLD. Results The patients in NAFLD group accounted for 55. 1% of all subjects,and the proportion of male patients was higher than that of female patients( 58. 0% vs 46. 7%,χ2= 4. 962,P = 0. 026). Compared with the control group,the NAFLD group had significantly higher body mass index( BMI),systolic pressure,diastolic pressure,alanine aminotransferase( ALT),fasting blood glucose,serum uric acid,and triglyceride( TG),a significantly higher proportion of male patients,and significantly higher proportions of patients with hypertension,diabetes,metabolic syndrome,newly- onset diabetes,and newly- onset metabolic syndrome( all P < 0. 05),as well as a significantly lower high- density lipoprotein cholesterol level( t =- 9. 818,P < 0. 001). Of all 374 patients in the control group,64( 17. 1%) had newly- onset NAFLD,and the incidence rate of newly- onset NAFLD showed no significant difference between male and female patients( 18% vs 15%,χ2= 0. 349,P > 0. 05); BMI and TG were the independent risk factors for newly- onset NAFLD( OR =1. 304,95% CI: 1. 153- 1. 474,P < 0. 001; OR = 1. 509,95% CI: 1. 080- 2. 166,P = 0. 016). At the end of follow- up in NAFLD group,235 patients( 51. 2%) achieved a stable disease,40( 8. 7%) achieved improvement,144( 31. 4%) achieved remission,and 40( 8. 7%) experienced aggravation. The increase in BMI increased the risk of aggravation of NAFLD( OR = 1. 163,95% CI: 1. 028- 1. 316,P = 0. 016),while reductions in BMI and serum uric acid were the protective factors against NAFLD( OR = 0. 849,95% CI: 0. 781-0. 923,P < 0. 001; OR = 0. 997,95% CI: 0. 995- 1. 000,P = 0. 038). Ten patients in NAFLD group died( including 5 patients with malignant tumor and 2 patients with cerebrovascular and cardiovascular diseases),and 6 patients in the control group died( including 2 patients with malignant tumor,no patients with cerebrovascular and cardiovascular diseases),and the risk of death showed no significant difference between the two groups( P > 0. 05). Conclusion The prognosis of NAFLD is relatively good in people who underwent physical examination,and BMI,TG,and serum uric acid are the factors affecting the prognosis of such patients. The major causes of death in NAFLD patients are malignant tumor and cerebrovascular and cardiovascular diseases,rather than end- stage liver disease.
[1]FUNG J,LEE CK,CHAN M,et al.High prevalence of non-alcoholic fatty liver disease in the Chinese-results from the Hong Kong liver health census[J].Liver Int,2015,35(2):542-549.
|
[2]BANG KB,CHO YK.Comorbidities and metabolic derangement of NAFLD[J].J Lifestyle Med,2015,5(1):7-13.
|
[3]ADAMS LA,LYMP JF,ST SAUVER J,et al.The natural history of nonalcoholic fatty liver disease:a population-based cohort study[J].Gastroenterology,2005,129(1):113-121.
|
[4]ONNERHAG K,NILSSON PM,LINDGREN S.Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD[J].Scand J Gastroenterol,2014,49(9):1111-1118.
|
[5]ZHOU YJ,LI YY,NIE YQ,et al.Natural course of nonalcoholic fatty liver disease in southern China:a prospective cohort study[J].J Dig Dis,2012,13(3):153-160.
|
[6]Group of Fatty Liver and Alcoholic Liver Diseases,Society of Hepatology,Chinese Medical Association.Guidelines for management of nonalcoholic fatty liver disease(revised in February 2006)[J].Mod Digest Interv,2007,12(4):266-268.(in Chinese)中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2006年2月修订)[J].现代消化及介入诊疗,2007,12(4):266-268.
|
[7]Group of Fatty Liver and Alcoholic Liver Diseases,Society of Hepatology,Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol,2010,26(2):120-124.(in Chinese)中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志,2010,26(2):120-124.
|
[8]LU YH,LU JM,WANG SY,et al.Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch[J].Natl Med J Chin,2006,86(6):386-389.(in Chinese)卢艳慧,陆菊明,王淑玉,等.国际糖尿病联盟与中国糖尿病学会关于代谢综合征诊断标准的比较分析[J].中华医学杂志,2006,86(6):386-389.
|
[9]YU S,GUO X,YANG H,et al.An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China[J].BMC Public Health,2014,14:877.
|
[10]ZHANG F,HUANG YQ,BAO ZJ.Prevalence of nonalcoholic fatty liver disease in urban areas in China[J].Chin J Dig,2014,34(6):430-432.(in Chinese)张帆,黄一沁,保志军.非酒精性脂肪性肝病在我国城市地区的流行现状[J].中华消化杂志,2014,34(6):430-432.
|
[11]HU X,HUANG Y,BAO Z,et al.Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units[J].BMC Gastroenterol,2012,12(35):123.
|
[12]FAN JG,ZHU J,LI XJ,et al.Prevalence of and risk factors for fatty liver in a general population of Shanghai,China[J].J Hepatol,2005,43(3):508-514.
|
[13]LI H,DONG K,FANG Q,et al.High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease:a 3-year prospective study in China[J].J Hepatol,2013,58(3):557-563.
|
[14]ZELBER-SAGI S,LOTAN R,SHLOMAI A,et al.Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up[J].J Hepatol,2012,56(5):1145-1151.
|
[15]SODERBERG C,PASKLING S,ASKLING J,et al.Decreased survival of subjects with elevated liver function tests during a 28-year follow-up[J].Hepatology,2010,51(2):595-602.
|
[16]ZHANG T,ZHANG C,ZHANG Y,et al.Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population:a prospective cohort study[J].Atherosclerosis,2015,240(1):144-148.
|
[17]HUANG CM,LI YY,ZHOU YJ,et al.Epidemiology of nonalcoholic fatty liver disease:a follow-up study for 4 years[J].Chin J Dig,2010,30(8):512-517.(in Chinese)黄春明,李瑜元,周永健,等.非酒精性脂肪性肝病流行病学4年对照研究[J].中华消化杂志,2010,30(8):512-517.
|
[18]SERTOGLU E,ERCIN CN,CELEBI G,et al.The relationship of serum uric acid with non-alcoholic fatty liver disease[J].Clin Biochem,2014,47(6):383-388.
|
[19]ANGULO P.Long-term mortality in nonalcoholic fatty liver disease:is liver histology of any prognostic significance[J].Hepatology,2010,51(51):373-375.
|
[20]DAM-LARSEN S,BECKER U,FRANZMANN MB,et al.Final results of a long-term,clinical follow-up in fatty liver patients[J].Scand J Gastroenterol,2009,44(10):1236-1243.
|
[21]EKSTEDT M,FRANZEN LE,MATHIESEN UL,et al.Longterm follow-up of patients with NAFLD and elevated liver enzymes[J].Hepatology,2006,44(4):865-873.
|
[22]LAZO M,HERNAEZ R,BONEKAMP S,et al.Non-alcoholic fatty liver disease and mortality among US adults:prospective cohort study[J].BMJ,2011,343(46):1245.
|
[1] | Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119 |
[2] | Bingbing ZHU, Jinxiang YANG, Qun ZHANG, Fangyuan GAO, Xianbo WANG. Risk factors for the 90-day prognosis of patients with type I hepatorenal syndrome and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2022, 38(7): 1561-1565. doi: 10.3969/j.issn.1001-5256.2022.07.019 |
[3] | Wanshu LIU, Lijun SHEN, Qinghui ZHAI, Shaojie XIN, Shaoli YOU. Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2532-2536. doi: 10.3969/j.issn.1001-5256.2022.11.018 |
[4] | Siqin LIU, Xiaomei WANG, Xia LI, Luwen LIANG, Ke WANG, Rui WANG. Covert hepatic encephalopathy in liver cirrhosis: Risk factors and prognosis[J]. Journal of Clinical Hepatology, 2022, 38(2): 359-364. doi: 10.3969/j.issn.1001-5256.2022.02.020 |
[5] | Ping ZHU, Heping ZHAO, Tao HAN, Qing YE, Tinghong LI, Huiling XIANG. Evaluation and influencing factors of the short-term prognosis of severe alcoholic hepatitis with different underlying liver diseases[J]. Journal of Clinical Hepatology, 2021, 37(2): 370-374. doi: 10.3969/j.issn.1001-5256.2021.02.024 |
[6] | Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015 |
[7] | Li Ying, Zhan Jing, Wang ZhongFeng. Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2017, 33(3): 497-501. doi: 10.3969/j.issn.1001-5256.2017.03.020 |
[8] | Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022 |
[9] | Cui YanPing, Li QingFang, Li QingYan, Liu ChunHua, Wang WeiHong, Yuan JianGuo, Wang SiKui. Logistic regression analysis of prognostic risk factors for hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2016, 32(1): 135-138. doi: 10.3969/j.issn.1001-5256.2016.01.026 |
[10] | Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018 |
[11] | Qiao LiNa, Dai GuangRong, Zhang Jin, Shen Ni. An epidemiological survey of prevalence and risk factors for fatty liver disease in adults residing in Yan'an,China[J]. Journal of Clinical Hepatology, 2015, 31(1): 82-87. doi: 10.3969/j.issn.1001-5256.2015.01.018 |
[12] | Chen YongFang, Wu ZhanJun. Pathogenesis and risk factors of cholesterol gallstones in patients with non- alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 952-955. doi: 10.3969/j.issn.1001-5256.2013.12.021 |
[13] | Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304. |
[14] | Zhang DongQing, Chen Li, Gan QiaoRong, Zhou Rui, Huang JianRong, Pan Chen. Prognostic factors for hepatitis B acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 740-743. |
[15] | Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155. |
[16] | Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792. |
[17] | Zhang YiNing, Du HongWei, Liu YanJun, Wang ChaoXia. The diagnosis and risk factors for evaluation of nonalcoholic fatty liver disease in children and adolescents[J]. Journal of Clinical Hepatology, 2011, 27(7): 690-693. |
[18] | Liu XiaoYan, Li ShengMian, Yang Jian. The incidence and prognosis of non-alcoholic fatty liver disease in primary liver cancer 1293 cases[J]. Journal of Clinical Hepatology, 2010, 26(6): 641-643. |
[19] | Chen MingWei, Yang MingGong, Wang YouMin, Wang ZhangJiang, Pan TianRong, Hu HongLin, Sun HaiYan. Risk factors analysis on nonalcoholic steatohepatitis in patients with type 2 diabetes[J]. Journal of Clinical Hepatology, 2004, 20(1): 44-45. |
[20] | Ding HuiGuo, Gao GuiJu, Chen Tao, Jin Rui. Prognosis of Severe Types of Virous Hepatitis: Study on Mutiple Risk Factors.[J]. Journal of Clinical Hepatology, 2002, 18(5): 297-299. |
1. | 董璐,曹雪艳,成路平,薛焕利,郭西伟,杨跃青. 苓桂术甘汤联合多烯磷脂酰胆碱治疗非酒精性脂肪肝病疗效观察. 海南医学. 2022(01): 36-38 . ![]() | |
2. | 赵新艳. 双歧三联活菌联合多烯磷脂胆碱治疗非酒精性脂肪性肝病的疗效观察. 山西医药杂志. 2022(08): 911-913 . ![]() | |
3. | 周涛,许杰,戚璐,徐俊,程良斌. 《内经》体质医学思想在非酒精性脂肪性肝病病因病机中的应用. 中国医药导报. 2021(16): 121-124 . ![]() | |
4. | 刘怀磊,龚卫红. 老年人BMI变化对非酒精性脂肪性肝病发病的影响研究. 中国初级卫生保健. 2020(09): 72-74 . ![]() | |
5. | 欧阳琴,王志音,马臻. 湖北某大学职工非酒精性脂肪性肝病流行病学调查及中西医结合治疗临床观察. 中西医结合肝病杂志. 2019(06): 510-512+519 . ![]() | |
6. | 张茹,王宏亮,张薇,王青青,钟玉玲,凡豪志,田亭,张留馨,王洁. 南京市某功能社区人群非酒精性脂肪性肝病的知信行调查及其影响因素分析. 现代预防医学. 2019(24): 4461-4466 . ![]() | |
7. | 张绍仁,胡静娴,樊晓明. siRNA抑制饥饿素-O-乙酰基转移酶对肝细胞脂肪变性的影响及作用机制. 临床肝胆病杂志. 2018(05): 1060-1067 . ![]() | |
8. | 黄文瀚,任飞凤,罗蕾,周俊,潘珠玛,郭晖,唐琳. 血管紧张素1-7对高脂诱导小鼠肝脏损伤的保护作用. 现代医药卫生. 2018(03): 344-345+348 . ![]() | |
9. | 李玉凤,杨琪,王建文,叶小慧,张曼卡,郝晓花,黄玉波,魏红山. CRISPR/Cas9介导的Fam171a1基因敲除大鼠基因型鉴定及基因功能的初步研究. 中国肝脏病杂志(电子版). 2017(01): 68-74 . ![]() |